FERRITO, MATTEO
FERRITO, MATTEO
Universita' degli Studi di MILANO
Early recognition of peripheral spondyloarthritis in inflammatory bowel disease: A prospective observational study integrating detail questionnaire screening, ultrasound-based diagnosis, and gut microbiota profiling
2026 F. Santagata, M. Ferrito, E.G. Favalli, R. Caporali, O. De Lucia, I. Honcharyuk, E. Panichi, F. Conforti, N.P. O Sed, L. Spina, B. Caridi, G. Trignani, L. Ingrao, M. Vecchi, F. Caprioli
The game-changer: ultrasound examination of distal interphalangeal joint swelling and nail psoriasis
2025 M. Ferrito, R. Fabbri, S. Sirotti, A. Altomare, R. Caporali, P.S. Puttini, G. Filippou
Ultrasound in rheumatic and musculoskeletal diseases: From musculoskeletal to organ involvement
2025 L. Kun, I. Gessl, G. Filippou, M. Ferrito, R. Giacomelli, P. Mandl
Expanding the expanded risk score to psoriatic arthritis: any port in a storm
2025 E.G. Favalli, L. Ingrao, G. Trignani, M. Ferrito, G. Cincinelli, R. Caporali
Difficult-to-treat psoriatic arthritis: refining the definition using a statistical model in a real-life cohort
2024 E.G. Favalli, G. Biganzoli, G. Cincinelli, M. Ferrito, E. Luconi, M. Manara, M. Biggioggero, P. Boracchi, R. Caporali
Updates in Ultrasound in Rheumatology
2024 G. Filippou, M.E. Pellegrino, A. Sorce, S. Sirotti, M. Ferrito, S. Gitto, C. Messina, D. Albano, L.M. Sconfienza
CPPD disease presenting with acute arthritis of the first metatarsophalangeal joint
2024 M. Ferrito, S. Sirotti, P. SARZI PUTTINI, R. Caporali, G. Filippou
Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients
2023 M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali
Effect of neridronate on axial involvement in patients with spondyloarthritis when biologics are not possible. Results of a monocentric study
2023 C. Crotti, R. Di Taranto, F. Orsini, M. Ferrito, M. Varenna, E.G. Favalli, R. Caporali
The impact of EMA recommendations on the real-life use of Janus kinases inhibitors for rheumatoid arthritis: the Expanded Risk Score in RA as a tool to quantify the risk of cardiovascular events
2023 E.G. Favalli, G. Cincinelli, S. Germinario, R. Di Taranto, F. Orsini, G. Maioli, M. Biggioggero, M. Ferrito, R. Caporali
Juvenile Idiopathic Arthritis, Uveitis and Multiple Sclerosis: Description of Two Patients and Literature Review
2022 C.B. Chighizola, M. Ferrito, L. Marelli, I. Pontikaki, P. Nucci, E. Miserocchi, R. Caporali